Mangoceuticals(MGRX) - 2024 Q2 - Quarterly Results

Financial Results - Mangoceuticals, Inc. reported financial results for the three and six months ended June 30, 2024[3]. - The press release regarding financial results was issued on August 15, 2024[3]. - The financial results are not deemed "filed" under the Securities Exchange Act of 1934[3]. Company Classification - The company is classified as an emerging growth company under the Securities Act[2]. - The trading symbol for the common stock is MGRX, listed on the Nasdaq Capital Market[2]. Forward-Looking Statements - The report includes forward-looking statements that may involve risks and uncertainties affecting future performance[5]. - The company has no obligation to update or revise forward-looking statements after the date they are made[5]. - The report includes cautionary statements regarding potential factors affecting financial results[5]. Company Information - The company’s principal executive office is located in Dallas, Texas[1]. - The company’s IRS Employer Identification Number is 87-3841292[1].